Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
Actigraphy
/ methods
Administration, Oral
Aged
Aged, 80 and over
Algorithms
Antiparkinson Agents
/ administration & dosage
Carbidopa
/ administration & dosage
Drug Combinations
Feasibility Studies
Female
Humans
Levodopa
/ administration & dosage
Male
Middle Aged
Parkinson Disease
/ diagnosis
Wearable Electronic Devices
Algorithmic suggestions
Levodopa
Oral medication
Parkinson’s disease
Sensor data
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
17
11
2018
accepted:
02
01
2019
pubmed:
20
1
2019
medline:
7
6
2019
entrez:
20
1
2019
Statut:
ppublish
Résumé
Dosing schedules for oral levodopa in advanced stages of Parkinson's disease (PD) require careful tailoring to fit the needs of each patient. This study proposes a dosing algorithm for oral administration of levodopa and evaluates its integration into a sensor-based dosing system (SBDS). In collaboration with two movement disorder experts a knowledge-driven, simulation based algorithm was designed and integrated into a SBDS. The SBDS uses data from wearable sensors to fit individual patient models, which are then used as input to the dosing algorithm. To access the feasibility of using the SBDS in clinical practice its performance was evaluated during a clinical experiment where dosing optimization of oral levodopa was explored. The supervising neurologist made dosing adjustments based on data from the Parkinson's KinetiGraph™ (PKG) that the patients wore for a week in a free living setting. The dosing suggestions of the SBDS were compared with the PKG-guided adjustments. The SBDS maintenance and morning dosing suggestions had a Pearson's correlation of 0.80 and 0.95 (with mean relative errors of 21% and 12.5%), to the PKG-guided dosing adjustments. Paired t test indicated no statistical differences between the algorithmic suggestions and the clinician's adjustments. This study shows that it is possible to use algorithmic sensor-based dosing adjustments to optimize treatment with oral medication for PD patients.
Identifiants
pubmed: 30659356
doi: 10.1007/s00415-019-09183-6
pii: 10.1007/s00415-019-09183-6
pmc: PMC6394802
doi:
Substances chimiques
Antiparkinson Agents
0
Drug Combinations
0
carbidopa, levodopa drug combination
0
Levodopa
46627O600J
Carbidopa
MNX7R8C5VO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
651-658Subventions
Organisme : VINNOVA
ID : 2014-03727
Références
Mov Disord. 2001 May;16(3):448-58
pubmed: 11391738
Neurology. 2005 Jan 25;64(2):216-23
pubmed: 15668416
Mov Disord. 2005;20 Suppl 11:S11-6
pubmed: 15822109
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Mov Disord. 2009 Apr 15;24(5):723-30
pubmed: 19133661
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Clin Neuropharmacol. 2011 Mar-Apr;34(2):61-5
pubmed: 21297456
CNS Neurosci Ther. 2012 May;18(5):380-7
pubmed: 22070400
J Neurol. 2013 Nov;260(11):2701-14
pubmed: 23287972
J Parkinsons Dis. 2012;2(1):47-55
pubmed: 23939408
J Parkinsons Dis. 2014;4(1):89-96
pubmed: 24398654
Sensors (Basel). 2014 Nov 11;14(11):21329-57
pubmed: 25393786
Mov Disord. 2016 Sep;31(9):1272-82
pubmed: 27125836
Mov Disord. 2016 Sep;31(9):1263-71
pubmed: 27273651
Eur J Clin Pharmacol. 2017 May;73(5):563-571
pubmed: 28101657
Acta Neurol Scand. 2017 Dec;136(6):727-731
pubmed: 28299787
Mov Disord. 2017 Aug;32(8):1147-1154
pubmed: 28605054
Int J Med Inform. 2018 Apr;112:137-142
pubmed: 29500011
CNS Neurosci Ther. 2018 May;24(5):439-447
pubmed: 29652438
IEEE J Biomed Health Inform. 2018 Sep;22(5):1341-1349
pubmed: 29989996
Mov Disord Clin Pract. 2016 Mar 24;3(3):221-229
pubmed: 30363573
Mov Disord. 1997 Jul;12(4):506-8
pubmed: 9251067